Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast plus mometasone versus mometasone alone in chronic asthma
2007-006097-28Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in asthma comparing Montelukast plus mometasone furoate with Mometasone furoate plus placebo (2 arms). Primary endpoints: Change from baseline in FEV1 over treatment period and Safety and tolerability. Started Feb 2008; status: completed.
02
Drugs
montelukastmometasone
03
Conditions
asthma
Beyond the preview
Go deeper on 2007-006097-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006097-28.